Zobrazeno 1 - 10
of 783
pro vyhledávání: '"vinflunine"'
Publikováno v:
Asian Pacific Journal of Cancer Biology, Vol 7, Iss 3, Pp 207-214 (2022)
Background: Vinflunine is the only cytotoxic agent that had been tested as a second line therapy in platinum refractory urothelial carcinoma patients in a phase III clinical trial. The aim of our study was to evaluate the efficacy and safety of vinfl
Externí odkaz:
https://doaj.org/article/bf4cb0f7fc79444ca5e8670a3a9392d6
Autor:
Aristotelis Bamias, Konstantinos Koutsoukos, Nikos Gavalas, Roubini Zakopoulou, Kimon Tzannis, Nikos Dedes, Anna Boulouta, Charalampos Fragkoulis, Eythymios Kostouros, Athanasios Dellis, Iraklis Mitsogiannis, Ioannis Adamakis, Ioannis Anastasiou, Andreas Skolarikos, Athanasios Papatsoris, Konstantinos Stravodimos, Nikolaos Ferakis, Stamatina Pagoni, Konstantinos Ntoumas, Dionysios Mitropoulos, Charalambos Deliveliotis, Constantinos A. Constantinides, Meletios A. Dimopoulos
Publikováno v:
Current Oncology, Vol 28, Iss 6, Pp 4474-4484 (2021)
We previously showed that ERCC1 19007 C>T polymorphism was associated with cancer-specific survival (CSS) after platinum-based chemotherapy in patients with advanced urothelial cancer (aUC). We aimed to confirm this association in a different cohort
Externí odkaz:
https://doaj.org/article/e08e09f7baec40e4ba61d84654ca1a30
Autor:
A. S. Zhabina, A. I. Novikov, F. V. Moiseenko, N. M. Volkov, E. O. Stepanova, E. V. Artemeva, N. H. Abduloeva, V. M. Moiseenko
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 8, Iss 2, Pp 34-42 (2021)
Purpose of the study. There is the generalized analysis of administration of vinflunine in real clinical practice in St.Petersburg Clinical Scientific and Practical Center of Specialized medical Care (oncological).Materials and methods. This analysis
Externí odkaz:
https://doaj.org/article/02ac5742c0f54e10b12b140e137026f4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Riedel, Felix
Die vorliegende Dissertation beschäftigt sich mit der Fragestellung, ob eine vorangegangene Therapie mit einem Checkpointinhibitor (CPI) bei Patienten mit metastasiertem Urothelkarzinom einen positiven Effekt auf eine Folgebehandlung mit dem Chemoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b02eb4a22c0d236ddc081eddd064c2fd
Autor:
Rodolfo Passalacqua, Silvia Lazzarelli, Maddalena Donini, Rodolfo Montironi, Rosa Tambaro, Ugo De Giorgi, Sandro Pignata, Raffaella Palumbo, Giovanni Luca Ceresoli, Gianluca Del Conte, Giuseppe Tonini, Franco Morelli, Franco Nolè, Stefano Panni, Ermanno Rondini, Annalisa Guida, Paolo Andrea Zucali, Laura Doni, Elisa Iezzi, Caterina Caminiti
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-10 (2017)
Abstract Background Vinflunine is the only chemotherapeutic agent shown to improve survival in platinum-refractory patients with metastatic transitional cell carcinoma of the urothelium (TCCU) in a phase III clinical trial, which led to product regis
Externí odkaz:
https://doaj.org/article/908c9733b96a4d20a13b5e2fbf50b4a0
Autor:
Iraklis Mitsogiannis, Anna Boulouta, Dionysios Mitropoulos, Charalampos Fragkoulis, Nikolaos Ferakis, Ioannis Adamakis, Nikos Dedes, Charalambos Deliveliotis, Andreas Skolarikos, Konstantinos Ntoumas, Constantinos Constantinides, Athanasios Papatsoris, Konstantinos Stravodimos, Stamatina Pagoni, Ioannis Anastasiou, Roubini Zakopoulou, Aristotelis Bamias, Meletios A. Dimopoulos, Konstantinos Koutsoukos, Kimon Tzannis, Nikos G. Gavalas, Eythymios Kostouros, Athanasios Dellis
Publikováno v:
Current Oncology, Vol 28, Iss 380, Pp 4474-4484 (2021)
Current Oncology
Volume 28
Issue 6
Pages 380-4484
Current Oncology
Volume 28
Issue 6
Pages 380-4484
We previously showed that ERCC1 19007 C>
T polymorphism was associated with cancer-specific survival (CSS) after platinum-based chemotherapy in patients with advanced urothelial cancer (aUC). We aimed to confirm this association in a different
T polymorphism was associated with cancer-specific survival (CSS) after platinum-based chemotherapy in patients with advanced urothelial cancer (aUC). We aimed to confirm this association in a different
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86f0bff6695463d8d05c18c7bc48232b
https://doi.org/10.3390/curroncol28060380
https://doi.org/10.3390/curroncol28060380
Publikováno v:
EJC Supplements, Vol 14, Iss 1, Pp 1-20 (2016)
Externí odkaz:
https://doaj.org/article/e5b74321133c474f9e37158b301f7e99
Autor:
Stephanie Burnett, Amit Bahl, Bruno Morgan, Lucy Tregellas, Lisa Pickering, Alastair Thomson, Emma Hall, Tony Elliott, Rachel Slade, Balaji Venugopal, Steve Nicholson, Naveen S. Vasudev, Holly Tovey, Clare Cruickshank, Peter Kirkbride, Alison Hassall, Anita Mitra
Publikováno v:
British Journal of Cancer
Background We investigated the first-line activity of vinflunine in patients with penis cancer. Cisplatin-based combinations are commonly used, but survival is not prolonged; many patients are unfit for such treatment or experience toxicity that outw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6709a5dc75da982f3b26a6c6831ed122
https://doi.org/10.1038/s41416-021-01574-9
https://doi.org/10.1038/s41416-021-01574-9